Dumitrascu T, Eftimie M, Aiordachioae A, Stroescu C, Dima S, Ionescu M, Popescu I. Male gender and increased body mass index independently predicts clinically relevant morbidity after spleen-preserving distal pancreatectomy. World J Gastrointest Surg 2018; 10(8): 84-89 [PMID: 30510633 DOI: 10.4240/wjgs.v10.i8.84]
Corresponding Author of This Article
Traian Dumitrascu, MD, PhD, Senior Lecturer, Department of General Surgery and Liver Transplant, Fundeni Clinical Institute, Fundeni Street no 258, Bucharest 022328, Romania. traian.dumitrascu@umfcd.ro
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Nov 27, 2018; 10(8): 84-89 Published online Nov 27, 2018. doi: 10.4240/wjgs.v10.i8.84
Male gender and increased body mass index independently predicts clinically relevant morbidity after spleen-preserving distal pancreatectomy
Traian Dumitrascu, Mihai Eftimie, Andra Aiordachioae, Cezar Stroescu, Simona Dima, Mihnea Ionescu, Irinel Popescu
Traian Dumitrascu, Mihai Eftimie, Andra Aiordachioae, Cezar Stroescu, Simona Dima, Mihnea Ionescu, Irinel Popescu, Department of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest 022328, Romania
Author contributions: All authors helped to perform the research and to write the manuscript; Dumitrascu T, Aiordachioae A, Eftimie M and Dima S contributed to drafting conception and design; Dumitrascu T and Aiordachioae A contributed to data analysis; Dumitrascu T, Stroescu C, Ionescu M and Popescu I contributed to performing procedures.
Institutional review board statement: This study was retrospective, and no interference with patients’ treatment was made. Thus, the approval by the Ethics Committee of the Fundeni Clinical Institute was waived.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous retrospective clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All authors declare no conflicts-of-interest related to this article.
Data sharing statement: No additional data are available.
Open-Access: This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author to: Traian Dumitrascu, MD, PhD, Senior Lecturer, Department of General Surgery and Liver Transplant, Fundeni Clinical Institute, Fundeni Street no 258, Bucharest 022328, Romania. traian.dumitrascu@umfcd.ro
Telephone: +40-21-3180417 Fax: +40-21-3180417
Received: August 1, 2018 Peer-review started: August 1, 2018 First decision: August 24, 2018 Revised: September 24, 2018 Accepted: November 4, 2018 Article in press: November 4, 2018 Published online: November 27, 2018 Processing time: 118 Days and 11.2 Hours
Core Tip
Core tip: No previous studies explored potential predictors of morbidity after spleen-preserving distal pancreatectomy (SPDP). The study aims to identify risk factors for clinically relevant complications after SPDP. Data of 41 patients with SPDP were reviewed and uni- and multivariate analyses were performed to assess potential predictors of clinically relevant morbidity, defined as complication ≥ grade 2 Dindo. The rate of clinically relevant complications was 19.5%. Male gender [odds ratio (OR): 1.29, 95%CI: 1.07-1.55, P = 0.005] and increased body mass index (OR: 23.18, 95%CI: 1.72-310.96, P = 0.018) were found as independent risk factors of clinically relevant morbidity after SPDP. These findings may assist a surgeon in clinical decision-making to better select patients suitable for SPDP.
